203 related articles for article (PubMed ID: 1784631)
1. Interactions of the catharanthus (Vinca) alkaloids with tubulin and microtubules.
Himes RH
Pharmacol Ther; 1991; 51(2):257-67. PubMed ID: 1784631
[TBL] [Abstract][Full Text] [Related]
2. Interaction of vinca alkaloids with tubulin: a comparison of vinblastine, vincristine, and vinorelbine.
Lobert S; Vulevic B; Correia JJ
Biochemistry; 1996 May; 35(21):6806-14. PubMed ID: 8639632
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of tubulin-microtubule polymerization by drugs of the Vinca alkaloid class.
Owellen RJ; Hartke CA; Dickerson RM; Hains FO
Cancer Res; 1976 Apr; 36(4):1499-502. PubMed ID: 1260766
[TBL] [Abstract][Full Text] [Related]
4. Binding of dolastatin 10 to tubulin at a distinct site for peptide antimitotic agents near the exchangeable nucleotide and vinca alkaloid sites.
Bai RL; Pettit GR; Hamel E
J Biol Chem; 1990 Oct; 265(28):17141-9. PubMed ID: 2211617
[TBL] [Abstract][Full Text] [Related]
5. Antimicrotubular drugs binding to vinca domain of tubulin.
Gupta S; Bhattacharyya B
Mol Cell Biochem; 2003 Nov; 253(1-2):41-7. PubMed ID: 14619954
[TBL] [Abstract][Full Text] [Related]
6. QM and QM/MD simulations of the Vinca alkaloids docked to tubulin.
Kelly EB; Tuszynski JA; Klobukowski M
J Mol Graph Model; 2011 Sep; 30():54-66. PubMed ID: 21798777
[TBL] [Abstract][Full Text] [Related]
7. Mechanism of interaction of vinca alkaloids with tubulin: catharanthine and vindoline.
Prakash V; Timasheff SN
Biochemistry; 1991 Jan; 30(3):873-80. PubMed ID: 1988072
[TBL] [Abstract][Full Text] [Related]
8. Triazolopyrimidines Are Microtubule-Stabilizing Agents that Bind the Vinca Inhibitor Site of Tubulin.
Sáez-Calvo G; Sharma A; Balaguer FA; Barasoain I; Rodríguez-Salarichs J; Olieric N; Muñoz-Hernández H; Berbís MÁ; Wendeborn S; Peñalva MA; Matesanz R; Canales Á; Prota AE; Jímenez-Barbero J; Andreu JM; Lamberth C; Steinmetz MO; Díaz JF
Cell Chem Biol; 2017 Jun; 24(6):737-750.e6. PubMed ID: 28579361
[TBL] [Abstract][Full Text] [Related]
9. Mechanism of action of antitumor drugs that interact with microtubules and tubulin.
Jordan MA
Curr Med Chem Anticancer Agents; 2002 Jan; 2(1):1-17. PubMed ID: 12678749
[TBL] [Abstract][Full Text] [Related]
10. [Thermodynamics of calmodulin and tubulin binding to the vinca-alkaloid vinorelbine].
Tsvetkov FO; Kulikova AA; Devred F; Zerniĭ EIu; Lafitte D; Makarov AA
Mol Biol (Mosk); 2011; 45(4):697-702. PubMed ID: 21954603
[TBL] [Abstract][Full Text] [Related]
11. New insights into Vinca alkaloids resistance mechanism and circumvention in lung cancer.
Zhang Y; Yang SH; Guo XL
Biomed Pharmacother; 2017 Dec; 96():659-666. PubMed ID: 29035832
[TBL] [Abstract][Full Text] [Related]
12. Aging of tubulin at neutral pH: the destabilizing effect of vinca alkaloids.
Prakash V; Timasheff SN
Arch Biochem Biophys; 1992 May; 295(1):137-45. PubMed ID: 1575510
[TBL] [Abstract][Full Text] [Related]
13. Microtubules as drug receptors: pharmacological properties of microtubule protein.
Wilson L
Ann N Y Acad Sci; 1975 Jun; 253():213-31. PubMed ID: 1096718
[No Abstract] [Full Text] [Related]
14. Novel aspects of natural and modified vinca alkaloids.
Duflos A; Kruczynski A; Barret JM
Curr Med Chem Anticancer Agents; 2002 Jan; 2(1):55-70. PubMed ID: 12678751
[TBL] [Abstract][Full Text] [Related]
15. Therapeutic selectivity of vinca alkaloids: a role for guanosine 5'-triphosphate?
Houghton PJ; Houghton JA; Bowman LC; Hazelton BJ
Anticancer Drug Des; 1987 Oct; 2(2):165-79. PubMed ID: 3329524
[TBL] [Abstract][Full Text] [Related]
16. Action of drugs on microtubules.
Wilson L
Life Sci; 1975 Aug; 17(3):303-9. PubMed ID: 1099380
[No Abstract] [Full Text] [Related]
17. Molecular docking and pharmacogenomics of vinca alkaloids and their monomeric precursors, vindoline and catharanthine.
Sertel S; Fu Y; Zu Y; Rebacz B; Konkimalla B; Plinkert PK; Krämer A; Gertsch J; Efferth T
Biochem Pharmacol; 2011 Mar; 81(6):723-35. PubMed ID: 21219884
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and evaluation of hybrid molecules targeting the vinca domain of tubulin.
Gherbovet O; Sánchez-Murcia PA; García Alvarez MC; Bignon J; Thoret S; Gago F; Roussi F
Org Biomol Chem; 2015 Mar; 13(10):3144-54. PubMed ID: 25634805
[TBL] [Abstract][Full Text] [Related]
19. Cryptophycin 1 binds to tubulin at a site distinct from the colchicine binding site and at a site that may overlap the vinca binding site.
Mooberry SL; Taoka CR; Busquets L
Cancer Lett; 1996 Oct; 107(1):53-7. PubMed ID: 8913266
[TBL] [Abstract][Full Text] [Related]
20. The spongistatins, potently cytotoxic inhibitors of tubulin polymerization, bind in a distinct region of the vinca domain.
Bai R; Taylor GF; Cichacz ZA; Herald CL; Kepler JA; Pettit GR; Hamel E
Biochemistry; 1995 Aug; 34(30):9714-21. PubMed ID: 7626642
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]